Molecular basis of bacterial resistance to chloramphenicol and florfenicol

Stefan Schwarz1, Corinna Kehrenberg, Benoît Doublet

  • 1Institut für Tierzucht, Bundesforschungsanstalt für Landwirtschaft (FAL), Höltystrasse 10, 31535 Neustadt-Mariensee, Germany. stefan.schwarz@fal.de

FEMS Microbiology Reviews
|November 13, 2004
PubMed

Insights

Chloramphenicol (Cm) and florfenicol (Ff) are potent protein synthesis inhibitors. This review details resistance mechanisms, including acetyltransferases and transporters, and their spread via mobile genetic elements.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • Chloramphenicol (Cm) and florfenicol (Ff) are critical antibiotics inhibiting bacterial protein biosynthesis.
  • Widespread use of Cm has led to significant bacterial resistance.
  • Florfenicol (Ff), a derivative, is used in veterinary medicine, with fewer known cross-resistance mechanisms.

Purpose of the Study:

  • To provide a comprehensive overview of resistance mechanisms against Cm and Ff.
  • To focus on chloramphenicol acetyltransferases (CATs), efflux pumps, and multidrug transporters.
  • To analyze the genetic basis and spread of resistance genes.

Main Methods:

  • Review of existing literature on Cm and Ff resistance.
  • Construction of phylogenetic trees for CAT and exporter proteins using multisequence alignment.
  • Analysis of mobile genetic elements associated with resistance genes.

Main Results:

  • Identified key resistance mechanisms including enzymatic inactivation (CATs) and active efflux (transporters).
  • Demonstrated that only a subset of Cm resistance genes confer Ff resistance.
  • Highlighted the role of mobile genetic elements in the dissemination of both Cm and Cm/Ff resistance.

Conclusions:

  • Understanding resistance mechanisms is crucial for effective antibiotic use.
  • Phylogenetic analysis provides insights into the evolution of resistance proteins.
  • Mobile genetic elements facilitate the spread of resistance, even without direct antibiotic pressure.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...